EMAIL THIS PAGE TO A FRIEND

Disease models & mechanisms

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.


PMID 24558096

Abstract

Epstein-Barr virus (EBV) is tightly associated with certain human cancers, but there is as yet no specific treatment against EBV-related diseases. The EBV-encoded EBNA1 protein is essential to maintain viral episomes and for viral persistence. As such, EBNA1 is expressed in all EBV-infected cells, and is highly antigenic. All infected individuals, including individuals with cancer, have CD8(+) T cells directed towards EBNA1 epitopes, yet the immune system fails to detect and destroy cells harboring the virus. EBV immune evasion depends on the capacity of the Gly-Ala repeat (GAr) domain of EBNA1 to inhibit the translation of its own mRNA in cis, thereby limiting the production of EBNA1-derived antigenic peptides presented by the major histocompatibility complex (MHC) class I pathway. Here we establish a yeast-based assay for monitoring GAr-dependent inhibition of translation. Using this assay we identify doxorubicin (DXR) as a compound that specifically interferes with the GAr effect on translation in yeast. DXR targets the topoisomerase-II-DNA complexes and thereby causes genomic damage. We show, however, that the genotoxic effect of DXR and various analogs thereof is uncoupled from the effect on GAr-mediated translation control. This is further supported by the observation that etoposide and teniposide, representing another class of topoisomerase-II-DNA targeting drugs, have no effect on GAr-mediated translation control. DXR and active analogs stimulate, in a GAr-dependent manner, EBNA1 expression in mammalian cells and overcome GAr-dependent restriction of MHC class I antigen presentation. These results validate our approach as an effective high-throughput screening assay to identify drugs that interfere with EBV immune evasion and, thus, constitute candidates for treating EBV-related diseases, in particular EBV-associated cancers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA035775
Anti-D4S234E antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2105613
Anti-D4S234E, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2101297
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
HPA049830
Anti-KRAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107115
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
SAB2700181
Anti-NS3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2502090
Anti-Nsg1 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4501190
Anti-NSG1 antibody produced in rabbit, affinity isolated antibody
SAB4503030
Anti-TCTP antibody produced in rabbit, affinity isolated antibody
E2600000
Etoposide, European Pharmacopoeia (EP) Reference Standard
C29H32O13
Y0001365
Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard
C29H32O13
I1656 Idarubicin hydrochloride, solid
C26H27NO9 · HCl
M9140
Methylene blue, certified by the Biological Stain Commission
C16H18ClN3S · xH2O
03978
Methylene Blue solution, for microscopy, concentrate according to Ehrlich, concentrated, aqueous solution
C16H18ClN3S
1808
Methylene Blue solution, 1.4 % (w/v) in 95% ethanol
C16H18ClN3S
319112
Methylene Blue solution, 0.05 wt. % in H2O
C16H18ClN3S
77515
Methylene Blue solution, for microscopy
C16H18ClN3S
50484
Methylene Blue solution, for microbiology
C16H18ClN3S
66725
Methylene Blue solution alkaline according to Loeffler, according to Loeffler
C16H18ClN3S
R3400 Monoclonal Anti-c-K-Ras antibody produced in mouse, clone 234-4.2, purified immunoglobulin, buffered aqueous solution
WH0027065M1
Monoclonal Anti-D4S234E antibody produced in mouse, clone 1C3, purified immunoglobulin, buffered aqueous solution
WH0003845M1
Monoclonal Anti-KRAS antibody produced in mouse, clone 3B10-2F2, purified immunoglobulin, buffered aqueous solution
SAB1404011
Monoclonal Anti-KRAS antibody produced in mouse, clone 4F3, purified immunoglobulin, buffered aqueous solution
SAB4100599
Monoclonal Anti-KRAS antibody produced in mouse, clone KRAS-A582, culture supernatant
SAB4100600
Monoclonal Anti-KRAS antibody produced in mouse, clone KRAS-B582, culture supernatant
WH0007178M1
Monoclonal Anti-TPT1 antibody produced in mouse, clone 3C7, purified immunoglobulin, buffered aqueous solution
P8624
Pirarubicin, ≥95% (HPLC)
C32H37NO12